Infranity provides significant financing to Alliance Ireland to fund part of the Company’s acquisition and growth plans

Published on 28/03/2024

Infranity, a prominent European infrastructure investor, is pleased to announce that it has entered into the financing of Alliance Ireland, which offers an extensive range of complex imaging (MRI, CT, PET-CT) and other modalities (X-Ray, Dexa and Ultrasound). The Company is an integral part of the Irish healthcare system and plays a crucial role in reducing long waiting lists for patients accessing essential diagnostics in Ireland. Alliance Ireland is part of the wider Alliance Medical Group, freshly acquired by experienced investment manager iCON Infrastructure in 2024.

DISCLAIMERS & CO

Welcome to Infranity’s website. Infranity is an asset management company authorized by the “Authorité des Marchés Financiers” under number GP-19000030. French “Société par Actions Simplifiée” – SAS, its registered office at 6 rue Ménars, 750002 Paris under the number 831 266 721 RCS.

This website is targeted at institutional, professional and qualified investors only.

The information, analyses, data and rates published on this website are for information purposes, are not contractually binding and can be modified without notice. They do not constitute a purchase or sale offer, nor investment advice, nor any commitment whatsoever on behalf of Infranity. This information is not exhaustive, may evolve over time and may be updated without notice and at any time. The company reserves the right to suspend, discontinue or cancel access to all or part of this website in the event of technical problems or force majeure.

US PERSONS

The information contained in this site is not intended for nationals or citizens of the United States of America or “US Persons” as defined by “Regulation S” of the Securities and Exchange Commission under the US Securities Act of 1933, which notably applies to any natural person residing in the United States of America and any partnership or corporation organized or registered under US regulations. If you are a “US Person”, you are not authorized to access this website.

Your access to this site is subject to compliance with the French legislation in force and to the “Legal notice” of the website.

By choosing to access our website, you acknowledge having read these terms and conditions and agree with them. In your interest, we recommend that you read them carefully.

Do you accept the conditions mentioned above and confirm that you understand them?